期刊文献+

洛赛克、羟氨苄青霉素合并硫糖铝三联疗法对根除幽门螺杆菌的研究 被引量:1

Tripletherapy with losec,amoxicillin andsucralfateforeradication of Helicobacter pyloriin duodenalulcer disease
原文传递
导出
摘要 目的 探讨洛赛克、羟氨苄青霉素合并硫糖铝三联疗法对根除幽门螺杆菌(Hp) 的疗效。方法 将83 例Hp 阳性十二指肠溃疡患者随机分为2 组。A 组42 例,以洛赛克20mg、每日2 次,羟氨苄青霉素500mg、每日4 次和硫糖铝1000mg、每日4 次,治疗2 周:B组41 例,以洛赛克20mg、每日2 次和羟氨苄青霉素500mg、每日4 次,治疗2 周作为对照组。在治疗前和疗程结束4 周以上,用快速尿素酶试验和组织学改良Giemsa 染色法检查Hp。结果 A 组的Hp 根除率为92.9% ,明显高于B 组的70.7% (P<0 .01)。A、B两组副反应小,均能耐受。结论 洛赛克、羟氨苄青霉素合并硫糖铝三联疗法的Hp 根除率高、安全,耐受性好,所用的硫糖铝副反应小,价廉。可作为洛赛克加羟氨苄青霉素二联疗法的补充,是一种新的较为理想的Hp 根除方案。 Objective To evaluate a new tripletherapy with Losec 20mg bid plusamoxicillin 500mg qid and sucralfate 1000mg qid for two weeks (group A) versus double therapy with Losec 20mg bid plus amoxicillin 500mg qidfortwo weeks(group B). Methods 83 patients with duodenal ulcerand helicobacter pylori(Hp)infection were randomly dividedinto 2 groups. Group A(n= 42) treated with triple therapy for two weeks.Group B(n= 41) treated with doubletherapy fortwo weeks.The Hp status was determined by rapid ureasetestand historyof Giemsa Stain beforeandfour weeksaftercompletion oftherapy.Results The eradication rate of group A(92.9 %)wassignificantly higherthan that of group B(70 .7% ),( P< 0 .01) . Side effects were minor. Conclusions Two week triple therapy with Losec. Amoxicillin and Sucralfate is highly effective,safeand well toleratedtreatmentforeradication of Hpinfection and may be an alternativeto Losec amoxicillin doubletherapy.
出处 《中华消化杂志》 CAS CSCD 北大核心 1999年第S1期18-20,共3页 Chinese Journal of Digestion
关键词 洛赛克 羟氨苄青霉素 硫糖铝 幽门螺杆菌 Losec Amoxicillin Sucralfate Helicobacter pylor
  • 相关文献

参考文献10

  • 1胡伏莲,黄志烈,王菊梅,贾博琦,刘新光,谢鹏雁.幽门螺杆菌的根除及其在十二指肠溃疡愈合和复发中的作用[J].中华消化杂志,1996,16(2):106-107. 被引量:109
  • 2Marks IN,Johnston DA,Young GO.Acid secretory changes andearly relapse following duodenalulcer with ranitidine and sucralfate. The American Journal of Medicine . 1991
  • 3Marks IN,WrightJP,Lucke W,etal.Relapse ratesafterinitialulcer healing with sucralfate and cimetidine. Scandinavian Journal of Gastroenterology . 1982
  • 4Slomiang BL,PiotrowskiJ,Slomiang A.Effect of Sucralfate on thedegradation of human gastric mucus by Helicobacter pylori proteaseandlipase. The American journal of Gastroenterology . 1992
  • 5Hui WM,Lan SK,HOJ,et al.Effect ofsucralfate and cimetidineon duodenalulcer associated antralgastritis and campylobacter pylori. The American Journal of Medicine . 1989
  • 6Low w JA,Zak J,Lucke W,etal.Tripletherapy with sucralfateisas effective as triple therapy containing bismuth in eradicating Helicobacter pylori and reducing duodenal ulcer relapse rates. Scandinavian Journal of Gastroenterology . 1992
  • 7Bertoni G,Sassatelli R,Nigrisoli E,et al.Triple therapy withazithromycin.omeprazole.and amoxicillin is highly effective in theeradication of Helicobacter pylori:acontrolled trialversusomeprazoleplus amoxicillin. The American journal of Gastroenterology . 1996
  • 8Piotrowski J,Majka J,Slomiang A,et al.Sucralfate affects thesusceptibility of H.pylori to antimicrobial agent( Abstr). The American journal of Gastroenterology . 1994
  • 9Slomiany BL,Murty VLN,Piotrowski J,et al.Glycosulfatase activity of H.pyloritoward human gastric mucin :effect ofsucralfate. The American journal of Gastroenterology . 1992
  • 10Banerjee S,Elomar E,Mowat A,et al.Sucralfate suppresses Helicobacter pyloriinfection and reduces gastric acid secretion by 50 % inpatients with duodenal ulcer. Gastroenterology . 1996

二级参考文献1

  • 1胡伏莲,中华消化杂志,1988年,27卷,205页

共引文献108

同被引文献1

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部